the Effect of Vitamin B 1 on Menstrual Pattern After Insertion of the IUD.
NCT05971680 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2023-08-02
Summary
investigate the effect of vitamin B 1 on menstrual bleeding and spotting after insertion of the IUD.
Conditions
- Intra-uterine Device Complication
Interventions
- DRUG
-
VITAMIN B1 500mg
VITAMIN B1 (High Potency) 500mg tab every day for 3 months
- DEVICE
-
intra-uterine contraceptive device
intra-uterine contraceptive device
Sponsors & Collaborators
-
Beni-Suef University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-30
- Primary Completion
- 2023-11-30
- Completion
- 2023-11-30
Countries
- Egypt
Study Locations
More Related Trials
-
Pretreatment With Mifepristone Prior to Mirena Insertion
NCT01931657 ·Status: COMPLETED ·Phase: PHASE2
-
Transdermal Contraceptive Patch - Endometrial Effects Study
NCT00896571 ·Status: COMPLETED ·Phase: PHASE2
-
Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
NCT00393198 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
NCT01499602 ·Status: COMPLETED ·Phase: NA
-
Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD
NCT02616731 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
NCT02475356 ·Status: COMPLETED
-
Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot Study
NCT01309919 ·Status: COMPLETED ·Phase: NA
-
Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)
NCT01254799 ·Status: COMPLETED ·Phase: PHASE3
-
Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)
NCT01295294 ·Status: COMPLETED ·Phase: PHASE4
-
Hysteroscopic Findings in Women Using Progesterone Only Pills (Minipills)
NCT05024604 ·Status: UNKNOWN
-
The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth
NCT02571296 ·Status: UNKNOWN ·Phase: PHASE4
-
Norethindrone for the Delay of Menstruation
NCT03594604 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine
NCT05083065 ·Status: COMPLETED
-
Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception
NCT01902264 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
NCT02089620 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
NCT07229209 ·Status: COMPLETED ·Phase: NA
-
LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia
NCT04385667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion
NCT03106805 ·Status: WITHDRAWN ·Phase: NA
-
Mirena or Conventional Medical Treatment for Menorrhagia
NCT00864136 ·Status: COMPLETED
-
Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement
NCT01598662 ·Status: TERMINATED ·Phase: NA
-
AZD6140 Oral Contraceptive Interaction Study
NCT00685906 ·Status: COMPLETED ·Phase: PHASE1
-
Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level
NCT05742503 ·Status: COMPLETED
-
Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
NCT02943655 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives
NCT03383185 ·Status: COMPLETED
-
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
NCT00983957 ·Status: COMPLETED ·Phase: PHASE1